Fulvestrant-A (-C5H7F5)O) AC
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | Liv7rXjlxHQ |
|---|---|
| InChI | InChI=1S/C29H42O3/c1-4-5-6-7-8-9-10-11-21-18-22-19-23(31)12-13-24(22)25-16-17-29(3)26(28(21)25)14-15-27(29)32-20(2)30/h4,12-13,19,21,25-28,31H,1,5-11,14-18H2,2-3H3/t21-,25-,26+,27+,28-,29+/m1/s1 |
| InChIKey | PUZXXCRJOZATHD-LIHJZYAESA-N |
| Mol Weight | 438.7 g/mol |
| Molecular Formula | C29H42O3 |
| Exact Mass | 438.313395 g/mol |
| Enantiomer InChIKey | PUZXXCRJOZATHD-ZSUOQYPISA-N |
| Copyright | Copyright © 2024-2025 John Wiley & Sons, Inc. All Rights Reserved. |
|---|
| Copyright | Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
- Fulvestrant-A (-C5H7F5SO) ac
- (1S,3aS,3bR,4R,9bS,11aS)-7-hydroxy-11a-methyl-4-(non-8-en-1-yl)-2,3,3a,3b,4,5,9b,10,11,11a-\rdecahydro-1H-cyclopenta[a]phenanthren-1-yl acetate
Fulvestrant-A (-C5H7F5SO) 2me
17BETA-ACETOXY-7ALPHA-METHYL-3-METHOXY-9,13-ISO-1,3,5(10)-ESTRATRIENE
17ALPHA-ACETOXY-7-ALPHA-METHYL-3-METHOXY-9,13-ISO-1,3,5(10)ESTRATRIENE
7.ALPHA.-METHYL-ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL(3,17.BETA.-DI-ACETATE)
16.alpha.Fluoro-7.alpha.-{9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl}estra-1,3,5(10)-triene-3,17.beta.-diol
7.alpha.-(9-Hydroxynonyl)estra-1,3,5(10)-triene-3,16.beta.,17.beta.-triol
16.alpha.Fluoro-7.alpha.-{9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl}estra-1,3,5(10)-triene-3,17.beta.-diol
(7R,8R,9S,13S,14S,16S,17R)-3-(methoxymethoxy)-13-methyl-7-(9-oxidanylnonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16,17-diol
Estra-1,3,5(10)-triene-7.alpha.-methyl-3,17.beta.-diol(3,17.beta.-di-trimethylsilyl ether)
7.ALPHA.-METHYL-ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL-DI-TRIMETHYLSILYL ETHER
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.